Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L-VAD Technology is a medical device company focused on the development of innovative mechanical circulatory support systems for patients with chronic heart failure. The company's primary product is the Internal Ventricular Assist Device (iVAD), a unique pulsatile, para-aortic blood pump designed to assist the weakened left ventricle. Unlike many modern continuous-flow LVADs, the iVAD is engineered to operate in synchrony with the patient's natural cardiac cycle, preserving physiological pulsatility and potentially reducing complications associated with non-pulsatile flow. The technology is intended for long-term use as a permanent solution or as a bridge to recovery for patients who are not candidates for heart transplantation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L-VAD Technology.